MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 42 filers reported holding MERUS N V in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,349,044 | -15.3% | 142,029 | -5.5% | 0.13% | -4.4% |
| Q2 2023 | $3,955,767 | -10.1% | 150,238 | -37.2% | 0.14% | -10.5% |
| Q1 2023 | $4,398,557 | +48.6% | 239,052 | +24.9% | 0.15% | +35.4% |
| Q4 2022 | $2,960,262 | +1.0% | 191,355 | +30.8% | 0.11% | -7.4% |
| Q3 2022 | $2,930,000 | -9.4% | 146,264 | +2.4% | 0.12% | 0.0% |
| Q2 2022 | $3,234,000 | -22.0% | 142,860 | -8.9% | 0.12% | -3.9% |
| Q1 2022 | $4,146,000 | -26.1% | 156,801 | -11.2% | 0.13% | -18.6% |
| Q4 2021 | $5,613,000 | +6.3% | 176,509 | -26.5% | 0.16% | +4.7% |
| Q3 2021 | $5,281,000 | +16.6% | 240,037 | +11.7% | 0.15% | +41.9% |
| Q2 2021 | $4,530,000 | +0.9% | 214,974 | 0.0% | 0.10% | +5.0% |
| Q1 2021 | $4,491,000 | +11.8% | 214,974 | -6.2% | 0.10% | +8.7% |
| Q4 2020 | $4,018,000 | +75.8% | 229,233 | +20.4% | 0.09% | +61.4% |
| Q3 2020 | $2,285,000 | -25.4% | 190,408 | 0.0% | 0.06% | -18.6% |
| Q2 2020 | $3,064,000 | +19.0% | 190,408 | -10.5% | 0.07% | +7.7% |
| Q1 2020 | $2,574,000 | +7.5% | 212,753 | +25.1% | 0.06% | +38.3% |
| Q4 2019 | $2,395,000 | -3.4% | 170,112 | +22.3% | 0.05% | -14.5% |
| Q3 2019 | $2,479,000 | -4.3% | 139,100 | -21.3% | 0.06% | -9.8% |
| Q2 2019 | $2,591,000 | -0.8% | 176,835 | 0.0% | 0.06% | -1.6% |
| Q1 2019 | $2,612,000 | +21.4% | 176,835 | +15.1% | 0.06% | -15.1% |
| Q4 2018 | $2,151,000 | +6.6% | 153,667 | +50.3% | 0.07% | +28.1% |
| Q3 2018 | $2,018,000 | -13.3% | 102,219 | 0.0% | 0.06% | +3.6% |
| Q2 2018 | $2,327,000 | +22.9% | 102,219 | 0.0% | 0.06% | +3.8% |
| Q1 2018 | $1,894,000 | -4.2% | 102,219 | 0.0% | 0.05% | +1.9% |
| Q4 2017 | $1,978,000 | -2.6% | 102,219 | 0.0% | 0.05% | +2.0% |
| Q3 2017 | $2,031,000 | +25.4% | 102,219 | 0.0% | 0.05% | +15.9% |
| Q2 2017 | $1,620,000 | -35.0% | 102,219 | 0.0% | 0.04% | -36.2% |
| Q1 2017 | $2,492,000 | +5.9% | 102,219 | -8.3% | 0.07% | 0.0% |
| Q4 2016 | $2,354,000 | +26.1% | 111,519 | 0.0% | 0.07% | +56.8% |
| Q3 2016 | $1,867,000 | +234.0% | 111,519 | +59.3% | 0.04% | +214.3% |
| Q2 2016 | $559,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |